
Real World Evidence can define treatment information
15 August 2019
- RWE provides many useful insights, and is currently being used primarily for RCT evidence supplementation
- ” …it’s clear that real-world data will play an increasingly important role in how drugs are assessed in the future.”“Industry, academia and the public sector will all have to work together to make this a real priority.”
– Dr Linda Landells, Associate Director at NICE
Click here to see the source article
About SVMPharma
SVMPharma is an innovative strategic consultancy, specialising in Real World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.
For more information, please visit www.svmpharma.com and contact us at enquiry@svmpharma.com